Bigfoot announced last July that it is beginning an exclusive relationship with Abbott’s Libre sensor system. The Libre is a flash glucose monitor, not a continuous glucose monitor. To get a glucose reading with the Libre requires an electronic inquiry by a hand-held receiver.
It’s likely that a future Bigfoot system would turn this flash monitor into a continuous monitor in that the manual BG inquiry would be automated. I think Bigfoot Biomedical provides hope that the insulin pump/CGM systems will not be completely dominated by Medtronic.